Spots Global Cancer Trial Database for Study of the Impact of DPD Activity on the Efficacy of Capecitabine

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Study of the Impact of DPD Activity on the Efficacy of Capecitabine

Official Title: Study of the Impact of DPD Activity on the Efficacy of Capecitabine

Study ID: NCT04198727

Conditions

Breast Neoplasm Malignant Female

Interventions

DPD activity assessment

Capecitabine

Study Description

Brief Summary: This study evaluates the Impact of DihydroPyrimidine Dehydrogenase (DPD) activity on the efficacy of Capecitabine in patients with metastatic breast cancer. The DPD phenotype before the initiation of treatment will be assess and then the patient will be follow up during the treatment with Capecitabine up to 24 month.

Detailed Description: